Avik Chatterjee, MD, MPH
Assistant Professor
Boston University School of Medicine
Dept of Medicine
General Internal Medicine

MD, University of North Carolina at Chapel Hill




Dr. Chatterjee is a med-peds trained primary care and addiction medicine physician at several shelter-based clinics through Boston Health Care for the Homeless Program. His areas of clinical and research interest include innovative treatment models for opioid use disorder in marginalized populations, and interventions on social determinants of health, such as food insecurity. He has an additional interest in racism and health care, particularly its manifestations in medical education and training.

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research


Faculty
Boston University School of Medicine
Medicine
Clinical Addiction Research and Education Unit




Evaluation of the Community Care in Reach(R) Mobile Addictio
12/01/2021 - 11/30/2022 (PI)
Massachusetts General Hospital


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Adams JW, Savinkina A, Fox A, Behrends CN, Madushani RWMA, Wang J, Chatterjee A, Walley AY, Barocas JA, Linas BP. Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs. Addiction. 2022 Oct; 117(10):2635-2648.View Related Profiles. PMID: 35315148
     
  2. Swartz N, Adnan T, Peréa F, Baggett TP, Chatterjee A. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness. J Subst Abuse Treat. 2022 Jul; 138:108752. PMID: 35277306
     
  3. Noyes EA, Dunleavy S, Mail V, Plakas I, Keyes S, Gaeta JM, Obando A, Paci E, Lent C, Regis C, Taveras EM, Yule AM, Chatterjee A. Awareness, Utilization, and Preferences of Harm Reduction Interventions among Street-Involved Young Adults in Boston. Subst Use Misuse. 2022; 57(5):827-832.View Related Profiles. PMID: 35195488
     
  4. Chatterjee A, Glasgow L, Bullard M, Sabir M, Hamilton G, Chassler D, Stevens-Watkins DJ, Goddard-Eckrich D, Rodgers E, Chaya J, Rodriguez S, Gutnick DN, Oga EA, Salsberry P, Martinez LS. Placing Racial Equity at the Center of Substance Use Research: Lessons From the HEALing Communities Study. Am J Public Health. 2022 02; 112(2):204-208. PMID: 35080947; PMCID: PMC8802575; DOI: 10.2105/AJPH.2021.306572;
     
  5. Nolen S, Zang X, Chatterjee A, Behrends CN, Green TC, Kumar A, Linas BP, Morgan JR, Murphy SM, Walley AY, Yan S, Schackman BR, Marshall BDL. Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island. Addiction. 2022 May; 117(5):1372-1381.View Related Profiles. PMID: 34825427; PMCID: PMC8983544; DOI: 10.1111/add.15759;
     
  6. Sandoval RS, Dunleavy S, Afolabi T, Said JT, Connor J, Hossain A, Kassamali B, Kienka T, Srinivasan M, Cheng A, Ölveczky D, Chatterjee A. Equity in medical education: Addressing microaggressions and discrimination on the wards. Med Teach. 2022 May; 44(5):551-558. PMID: 34860635
     
  7. Chatterjee A, Yan S, Xuan Z, Waye KM, Lambert AM, Green TC, Stopka TJ, Pollini RA, Morgan JR, Walley AY. Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts. Drug Alcohol Depend. 2022 01 01; 230:109190.View Related Profiles. PMID: 34864356; PMCID: PMC8714703; DOI: 10.1016/j.drugalcdep.2021.109190;
     
  8. Afolabi T, Borowsky HM, Cordero DM, Paul DW, Said JT, Sandoval RS, Davis D, Ölveczky D, Chatterjee A. Student-Led Efforts to Advance Anti-Racist Medical Education. Acad Med. 2021 06 01; 96(6):802-807. PMID: 33711839
     
  9. Morgan JR, Walley AY, Murphy SM, Chatterjee A, Hadland SE, Barocas J, Linas BP, Assoumou SA. Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort. Drug Alcohol Depend. 2021 08 01; 225:108764.View Related Profiles. PMID: 34051547; PMCID: PMC8488795; DOI: 10.1016/j.drugalcdep.2021.108764;
     
  10. McLaughlin MF, Li R, Carrero ND, Bain PA, Chatterjee A. Opioid use disorder treatment for people experiencing homelessness: A scoping review. Drug Alcohol Depend. 2021 07 01; 224:108717. PMID: 33985863
     
Showing 10 of 35 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 35 publications over 10 distinct years, with a maximum of 8 publications in 2021

YearPublications
20081
20121
20151
20163
20173
20186
20194
20204
20218
20224
Contact for Mentoring:

801 Massachusetts Avenue
Boston MA 02118
Google Map


Chatterjee's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department